Clinical Trial

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study to find out whether giving BIO 300 in combination with thoracic radiation therapy is effective in preventing pneumonitis in people with non-small cell lung cancer (NSCLC) and interstitial lung disease (ILD).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-06; most recent amendment 2026-03-02.
Trial Details
NCT Number NCT07323732
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions NSCLC, NSCLC, Stage I, NSCLC Stage II, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer Stage I, Non-small Cell Lung Cancer Stage II, Interstitial Lung Disease, Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)
Enrollment 25 participants
Start Date 2026-01-06
Primary Completion 2029-01-06 (estimated)
Study Completion 2029-01-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-03